AN ACT INCREASING THE BOND AUTHORIZATION FOR THE CONNECTICUT BIOSCIENCE INNOVATION FUND.
Connecticut increases state bond authority for bioscience innovation fund to expand biotech research and infrastructure investment capacity.
Connecticut increases state bond authority for bioscience innovation fund to expand biotech research and infrastructure investment capacity.
SB 124 increases the bond authorization available for Connecticut's Bioscience Innovation Fund, allowing the state to borrow more money to invest in bioscience research, development, and related infrastructure projects. The bill expands the financial capacity of an existing state program designed to support the life sciences and biotechnology sector in Connecticut.
Connecticut's bioscience sector is a significant employer and economic driver, and increased bond funding can accelerate research facilities, attract biotech companies, and create jobs in a high-value industry. Bond authorizations represent substantial public investment commitments, making this relevant to taxpayers who will ultimately service this debt through state revenues.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.